MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ACIU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AC Immune SA (ACIU) Ownership - Who owns AC Immune SA?

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
227.46M
P/E Ratio
N/A
Total Cash
74.8M
Projected Growth
N/A
Total Debt
4.3M
Revenue
3.7M
Risk (Beta)
2.92
Dividend Yield
N/A
Total Cash/Share
0.73
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ACIU
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ACIU
A.I. Advisor
published General Information

General Information

a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com